Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population

ConclusionsWhile results from this retrospective study suggest room for improvement in adherence to GLP-1RAs, medication adherence rates for patients initiating therapy with exenatide QW were higher than patients initiating therapy with exenatide BID or liraglutide QD. Further research is needed to validate these findings in other T2D patient populations.Funding: AstraZeneca Pharmaceuticals.

http://link.springer.com/10.1007/s12325-016-0470-y

Source: Advances in Therapy - January 10, 2017 Category: Drugs & Pharmacology Source Type: research